Inhalable ROS-Responsive Biguanide-Functionalized Chitosan Nanoparticles for Catalase Delivery and Pulmonary Immunomodulation in Acute Lung Injury
Biomacromolecules · 09.11.2026 · 27 (11) · 7788-7804
DOI: 10.1021/acs.biomac.6c01972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 23.10.2026. Verfasst von Meiling Piao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care Medicine, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin300100, China. Hauptthemen laut MEDLINE: Chitosan, Acute Lung Injury, Nanoparticles, Biguanides. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Tianjin Key Medical Discipline Construction Project.
Abstract (Originalsprache)
Acute lung injury (ALI) is characterized by excessive inflammation and oxidative stress, with limited effective pharmacological treatments. Herein, we developed a ROS-responsive nanoplatform, termed GCS−CAT@TK, consisting of a self-assembled core formed by biguanide-functionalized chitosan (GCS) and catalase (CAT), coated with a thioketal-linked PEGylated lipid (DSPE-TK-PEG2000) shell. GCS−CAT@TK sequentially facilitated mucus penetration, enhanced cellular internalization, and enabled ROS-responsive CAT release in inflamed lungs. In a lipopolysaccharide-induced ALI mouse model, GCS−CAT@TK effectively scavenged excess ROS, interrupted the self-amplifying cycle of oxidative stress, and promoted pulmonary tissue repair. Furthermore, GCS−CAT@TK effectively reduced neutrophil infiltration, shifted macrophages toward an anti-inflammatory phenotype, and increased regulatory T-cell abundance, thereby remodeling the pulmonary immune microenvironment. Mechanistic analyses indicated that these therapeutic effects were associated with modulation of NF-κB pathway and restoration of epithelial junction integrity. Collectively, GCS−CAT@TK offers a promising approach to ROS-responsive enzyme delivery and immune regulation for ALI therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Critical Care Medicine, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin300100, China.
- State Key Laboratory of Chemical Engineering and Low-Carbon Technology, Tianjin University, Tianjin300072, P. R. China.
- Institute of Integrative Medicine for Acute Abdominal Diseases, Tianjin300100, China.
- Tianjin Key Laboratory of Acute Abdomen Disease Associated Organ Injury and ITCWM Repair, Tianjin300100, China.
ORCID-Profile: Maolin Li
Förderung
- Tianjin Key Medical Discipline Construction Project
Zitieren
APA
Piao, M., Li, M., Ma, Y., Wu, Y., Gong, L., & Yu, J. (2026). Inhalable ROS-Responsive Biguanide-Functionalized Chitosan Nanoparticles for Catalase Delivery and Pulmonary Immunomodulation in Acute Lung Injury. Biomacromolecules, 27(11), 7788-7804. https://doi.org/10.1021/acs.biomac.6c01972
Vancouver
Piao M, Li M, Ma Y, Wu Y, Gong L, Yu J. Inhalable ROS-Responsive Biguanide-Functionalized Chitosan Nanoparticles for Catalase Delivery and Pulmonary Immunomodulation in Acute Lung Injury. Biomacromolecules. 2026;27(11):7788-7804. doi:10.1021/acs.biomac.6c01972
BibTeX
@article{Piao2026,
author = {Piao, Meiling and Li, Maolin and Ma, Yihan and Wu, Ya and Gong, Lirong and Yu, Jianbo},
title = {Inhalable ROS-Responsive Biguanide-Functionalized Chitosan Nanoparticles for Catalase Delivery and Pulmonary Immunomodulation in Acute Lung Injury},
journal = {Biomacromolecules},
year = {2026},
volume = {27},
number = {11},
pages = {7788--7804},
doi = {10.1021/acs.biomac.6c01972}
}
EUVIMED